In a Form 4 filing with the SEC, CEO, 10% Owner of MannKind Corp. (MNKD), discloses buying 700,000 shares of MNKD on 01/12/2011 at an average price of $8.71 p/sh for a total of $2,800,000.
MannKind Corp has a market cap of $1.12 billion; its shares were trading during Wednesday afternoon trading at around $9.01 with a PEG ratio of (0.10).
Mankind is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer. The co. was founded in 1991 and is based in Valencia, California.
Risk Our Money Not Yours | Get 50% Off Any Account
Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!
Leave a Reply